Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Xenetic Biosciences Inc | XBIO | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
3.83 | 3.83 | 3.925 | 3.925 | 3.85 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
12/2/2024 | 08:15 | EDGAR2 | Form 8-K - Current report |
18/12/2023 | 16:18 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
18/12/2023 | 16:16 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
08/12/2023 | 16:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
08/12/2023 | 16:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
08/12/2023 | 16:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
08/12/2023 | 16:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
08/12/2023 | 16:00 | EDGAR2 | Form 8-K - Current report |
13/11/2023 | 16:00 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
13/11/2023 | 07:30 | EDGAR2 | Form 8-K - Current report |
09/11/2023 | 16:00 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
18/9/2023 | 11:21 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
11/8/2023 | 07:05 | EDGAR2 | Form 8-K - Current report |
10/8/2023 | 15:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |